company background image
INCR

InterCure TASE:INCR Stock Report

Last Price

₪4.60

Market Cap

₪209.8m

7D

7.5%

1Y

-72.1%

Updated

29 Nov, 2023

Data

Company Financials +

INCR Stock Overview

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally.

INCR fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance1/6
Financial Health3/6
Dividends0/6

InterCure Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for InterCure
Historical stock prices
Current Share Price₪4.60
52 Week High₪16.69
52 Week Low₪3.95
Beta0.58
1 Month Change9.26%
3 Month Change-21.72%
1 Year Change-72.12%
3 Year Change-71.02%
5 Year Change-80.52%
Change since IPO-100.00%

Recent News & Updates

Recent updates

These 4 Measures Indicate That InterCure (TLV:INCR) Is Using Debt Reasonably Well

Feb 16
These 4 Measures Indicate That InterCure (TLV:INCR) Is Using Debt Reasonably Well

What InterCure Ltd.'s (TLV:INCR) P/E Is Not Telling You

Sep 19
What InterCure Ltd.'s (TLV:INCR) P/E Is Not Telling You

Here's Why InterCure (TLV:INCR) Can Manage Its Debt Responsibly

Aug 22
Here's Why InterCure (TLV:INCR) Can Manage Its Debt Responsibly

InterCure (TLV:INCR) Seems To Use Debt Quite Sensibly

Feb 14
InterCure (TLV:INCR) Seems To Use Debt Quite Sensibly

These 4 Measures Indicate That InterCure (TLV:INCR) Is Using Debt Reasonably Well

Sep 11
These 4 Measures Indicate That InterCure (TLV:INCR) Is Using Debt Reasonably Well

What Percentage Of InterCure Ltd (TLV:INCR) Shares Do Insiders Own?

Mar 08
What Percentage Of InterCure Ltd (TLV:INCR) Shares Do Insiders Own?

Shareholders Are Raving About How The InterCure (TLV:INCR) Share Price Increased 936%

Jan 12
Shareholders Are Raving About How The InterCure (TLV:INCR) Share Price Increased 936%

Is InterCure (TLV:INCR) Using Debt Sensibly?

Dec 04
Is InterCure (TLV:INCR) Using Debt Sensibly?

Shareholder Returns

INCRIL PharmaceuticalsIL Market
7D7.5%5.4%2.4%
1Y-72.1%-56.7%-10.4%

Return vs Industry: INCR underperformed the IL Pharmaceuticals industry which returned -56.7% over the past year.

Return vs Market: INCR underperformed the IL Market which returned -10.4% over the past year.

Price Volatility

Is INCR's price volatile compared to industry and market?
INCR volatility
INCR Average Weekly Movement7.8%
Pharmaceuticals Industry Average Movement4.9%
Market Average Movement5.7%
10% most volatile stocks in IL Market9.3%
10% least volatile stocks in IL Market3.9%

Stable Share Price: INCR is more volatile than 75% of IL stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: INCR's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of IL stocks.

About the Company

FoundedEmployeesCEOWebsite
1994370Alex Rabinovichhttps://www.intercure.co

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in biomed sector.

InterCure Ltd. Fundamentals Summary

How do InterCure's earnings and revenue compare to its market cap?
INCR fundamental statistics
Market Cap₪209.77m
Earnings (TTM)₪20.90m
Revenue (TTM)₪414.79m

10.0x

P/E Ratio

0.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
INCR income statement (TTM)
Revenue₪414.79m
Cost of Revenue₪255.78m
Gross Profit₪159.02m
Other Expenses₪138.11m
Earnings₪20.90m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.46
Gross Margin38.34%
Net Profit Margin5.04%
Debt/Equity Ratio26.8%

How did INCR perform over the long term?

See historical performance and comparison